News Industry News EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism January 16, 2011
News Industry News Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US January 04, 2011
News Industry News Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis January 04, 2011
News Daily News Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients Kim Dalton September 03, 2009